(Q34657311)

3 August 2017

1 reference

title

Mechanisms of antibiotic resistance in Staphylococcus aureus (English)

1 reference

3 August 2017

main subject

antibiotic resistance

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

Annalisa Pantosti

1

0 references

Andrea Sanchini

object named as

Andrea Sanchini

series ordinal

2

0 references

Monica Monaco

object named as

Monica Monaco

series ordinal

3

0 references

publication date

1 June 2007

1 reference

3 August 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

323-334

1 reference

Antibacterial resistance worldwide: causes, challenges and responses

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

The problems of drug-resistant pathogenic bacteria. Extrachromosomal nature of drug resistance in Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Analysis of the beta-lactamase plasmid of borderline methicillin-susceptible Staphylococcus aureus: focus on bla complex genes and cadmium resistance determinants cadD and cadX.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

“Celbenin” - resistant Staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Meticillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Epidemiology of methicillin-resistant staphylococci in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Surveillance and epidemiology of MRSA bacteraemia in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

The growing menace of community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Seven novel variants of the staphylococcal chromosomal cassette mec in methicillin-resistant Staphylococcus aureus isolates from Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Recruitment of the mecA gene homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Identification of a variant "Rome clone" of methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin, responsible for an outbreak in an intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Vancomycin: a 50-year reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Antimicrobial resistance: the example of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Vancomycin resistance in gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Fluoroquinolone resistance among Gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Sampling the antibiotic resistome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Linezolid resistance in a clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Failure of Clindamycin Treatment of Methicillin-Resistant Staphylococcus aureus Expressing Inducible Clindamycin Resistance In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Combination antibiotic therapy for infective endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Is Methicillin-Resistant Staphylococcus aureus More Virulent than Methicillin-Susceptible S. aureus? A Comparative Cohort Study of British Patients with Nosocomial Infection and Bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Can beta-lactams be re-engineered to beat MRSA?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Anti-MRSA beta-lactams in development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Platensimycin is a selective FabF inhibitor with potent antibiotic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Prospects for a MRSA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

Derivatives of a vancomycin-resistant Staphylococcus aureus strain isolated at Hershey Medical Center.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.3.323

21 January 2018

Identifiers

DOI

10.2217/17460913.2.3.323

1 reference

3 August 2017

1 reference